Company intelligence / Profile preview

Landerleau Marine Technologies

Landerneau, Brittany, France

Ownership: Private
Development stage: Other

Overview

Landerleau Marine Technologies is a specialized marine biotechnology company focused on the discovery and development of novel bioactive compounds derived from marine organisms. The company leverages the unique biodiversity of marine ecosystems to identify potential therapeutic candidates for various human diseases. Its research primarily targets the extraction of secondary metabolites with antimicrobial, anti-inflammatory, and oncology-related properties. Landerleau Marine Technologies aims to bridge the gap between marine biology and pharmaceutical application through innovative screening and isolation techniques.

Industry: Biotech

Beyond the preview

Go deeper on Landerleau Marine Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Landerleau Marine Technologies.

Explore the full profile